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The circadian clock coordinates behavioral and
circadian cueswith availability and utilization of nutri-
ents. Proteasomal degradation of clock repressors,
such as cryptochrome (CRY)1, maintains periodicity.
Whethermacroautophagy, a quality control pathway,
degrades circadian proteins remains unknown. Here
we show that circadian proteins BMAL1, CLOCK,
REV-ERBa, and CRY1 are lysosomal targets, and
that macroautophagy affects the circadian clock by
selectively degradingCRY1. Autophagic degradation
of CRY1, an inhibitor of gluconeogenesis, occurs in a
diurnal window when rodents rely on gluconeogen-
esis, suggesting that CRY1 degradation is time-
imprinted to maintenance of blood glucose. High-fat
feeding accelerates autophagic CRY1 degradation
and contributes to obesity-associated hyperglyce-
mia. CRY1 contains several light chain 3 (LC3)-inter-
acting region (LIR)motifs, which facilitate the interac-
tion of cargo proteins with the autophagosome
marker LC3. Usingmutational analyses, we identified
two distinct LIRs on CRY1 that exert circadian
glycemic control by regulating CRY1 degradation,
revealing LIRs as potential targets for controlling
hyperglycemia.
INTRODUCTION
The circadian clock synchronizes behavioral and circadian cues
with nutrient availability and energy metabolism (Bass and Taka-
hashi, 2010; Perelis et al., 2015). Disrupting circadian rhythm
contributes to development of type II diabetes (Marcheva268 Cell Metabolism 28, 268–281, August 7, 2018 ª 2018 Elsevier Incet al., 2010). The mammalian clock consists of complex feed-
back loops wherein heterodimeric complexes of transcription
factors CLOCK (circadian locomotor output cycles kaput) and
BMAL1 (brain and muscle Arnt-like protein 1) initiate expression
of period (PER)1/2 and cryptochrome (CRY)1/2, which repress
their transcriptional activity (Darlington et al., 1998; Gekakis
et al., 1998; Griffin et al., 1999; Kume et al., 1999; Sangoram
et al., 1998). Expression of Bmal1 is controlled by a second
loop consisting of nuclear hormone receptor REV-ERBa, which
represses Bmal1 expression, and retinoid-related orphan recep-
tors (RORs) that drive Bmal1 expression (Guillaumond et al.,
2005; Preitner et al., 2002; Sato et al., 2004). CRY1 is a core clock
repressor that, along with PER, determines circadian periodicity
(Griffin et al., 1999; Kume et al., 1999), and degradation of PER
and CRY affects period length. While mutations in casein kinase
1 3tau lead to PER hyperphosphorylation and its proteasomal
degradation, which shortens period (Meng et al., 2008), muta-
tions in F box protein FBXL3 stabilize CRY1 by blocking its pro-
teasomal degradation, which lengthens period (Busino et al.,
2007; Godinho et al., 2007; Siepka et al., 2007). Ubiquitination
of CRY1 by SCF (Skp1-Cul1-FBXL3) complex (Xing et al.,
2013) and its proteasomal degradation regulate CRY1 stability.
Recent studies indicate that the F box protein FBXL21 opposes
the effect of FBXL3 on CRY1 degradation (Hirano et al., 2013;
Yoo et al., 2013), suggesting that multiple mechanisms regulate
turnover of CRY proteins. Whether macroautophagy (hereafter
autophagy) degrades circadian proteins remains unknown.
In addition to serving as a clock repressor, CRY1 suppresses
hepatic gluconeogenesis by regulating CREB/cAMP signaling,
by rhythmic repression of glucocorticoid receptor, and by
decreasing nuclear FoxO1 levels that downregulate gluconeo-
genic gene expression (Jang et al., 2016; Lamia et al., 2011;
Zhang et al., 2010). Since the liver clock is regulated by nutrients,
insulin, and glucagon, and since glucagon activates autophagy
(Deter and De Duve, 1967), we considered the possibility that
autophagy, regulation of liver clock, and glucose metabolism.
Figure 1. BMAL1, CLOCK, REV-ERBa, and
CRY1 Are Degraded by Lysosomes
(A) Scheme depicting use of lysosomal inhibitors
(Lys Inh) intraperitoneally (i.p.) in mice at indicated
time points.
(B–I) Immunoblots (IBs) and quantifications for net
lysosomal flux of each indicated protein in livers at
indicated time points in ad libitum-fed male mice
injected with vehicle or Lys Inh as in (A); n = 4–8.
(J) Graph comparing relative rates of lysosomal
degradation of each indicated circadian protein;
n = 4–8.
(K) IB for indicated proteins in homogenate (Hom)
and autophagosome (APh) fractions from livers at
7 p.m. Two independent experiments are shown
(n = 3 livers per APh sample).
(L and M) Co-immunoprecipitation (coIP) of LC3
and IB for indicated proteins from livers at 7 p.m.
(n = 7) and 3 p.m. (n = 3). Two independent coIP
experiments are shown for 7 p.m. IgG, immuno-
globulin G.
Values are mean ± SEM. In (C) and (D), *p < 0.05,
**p < 0.01, ***p < 0.001; compare indicated values
with the corresponding 7 p.m. value. One-way
ANOVA and Bonferroni correction. Ponceau is the
loading control. See also Figure S1.are interlinked. Autophagy degrades cytoplasmic contents in
lysosomes (He and Klionsky, 2009). Induction of autophagy oc-
curs by activation of class III PI3K complex and generation of
PI3Ps, which recruit autophagy (ATG) proteins to cellular sites
of autophagosome (APh) formation (He and Klionsky, 2009).
Activation of ATG7 initiates distinct conjugation cascades that
lipidate cytosolic LC3-I into APh-bound LC3-II (He and Klionsky,
2009). APhs sequester cytoplasmic contents for degradation in
lysosomes. Cargo sequestration requires interaction of their
LC3-interacting region (LIR) motifs, which are W/F/Y-X-X-I/L/V
sequences with LC3 (Birgisdottir et al., 2013). Analyses of
CRY1 protein revealed several LIR motifs that formed the mech-
anistic basis to explore whether CRY1 interacts with LC3.
Studies in Atg7 knockout livers have revealed roles for auto-
phagy in glycogen (Kern et al., 2016), glucose (Karsli-Uzunbas
et al., 2014), and lipid metabolism (Singh et al., 2009); however,
the mechanisms by which autophagy regulates glucose meta-
bolism remain unclear. Since loss of hepatic Atg7 via tail vein
injections of adeno-associated viruses (AAVs) (Atg7KOAAVCre)
led to hypoglycemia, we hypothesized that autophagy maintains
gluconeogenesis and blood glucose levels by degrading CRY1.
Here, we show that circadian proteins are lysosomal substrates,Cell Meand that CRY1 is degraded by autophagy
in a temporal manner. We show that auto-
phagic degradation of CRY1 releases its
repression on gluconeogenesis and in-
creases blood glucose levels. We unravel
the mechanism of autophagic CRY1
degradation by identifying the specific
LIR motifs on CRY1 that determine its
interaction with LC3. Finally, we show
that high-fat feeding decreases CRY1
protein levels in an autophagy-dependentmanner, and that restoring hepatic CRY1 levels reverses
obesity-associated hyperglycemia. Our studies reveal CRY1
LIR motifs as potential targets to control obesity-associated
hyperglycemia.
RESULTS
Temporal Degradation of Core Circadian Proteins in
Lysosomes
To determine if, and when during the circadian period, core
circadian proteins are degraded by autophagy, we administered
the lysosomal inhibitor leupeptin intraperitoneally in mice 2 hr
prior to collection of livers at 7 a.m., 11 a.m., 3 p.m., 7 p.m.,
11 p.m., and 3 a.m. (Figure 1A). Livers were homogenized and
immunoblotted for LC3, clock inducers BMAL1 and CLOCK,
and repressors PER1, PER2, CRY1, and REV-ERBa (Figures
1B and S1A). Accumulation of a protein at a given time point in
the presence of leupeptin indicates its flux through lysosomes
indicating degradation. Quantification of LC3-II flux (Figure 1C)
revealed that induction of autophagy in livers from ad libitum-
fed mice occurred between 3 p.m. and 11 p.m. with maximal
activation at 7 p.m. Strikingly, lysosomal degradation of CRY1tabolism 28, 268–281, August 7, 2018 269
(Figure 1D) also occurred between 3 p.m. and 11 p.m. and
peaked at 7 p.m., coinciding with induction of autophagy. Immu-
noblotting of lysosome fractions from livers at each time point (as
in Figure 1A) confirmed that CRY1 is indeed a lysosomal sub-
strate that undergoes maximal degradation at 7 p.m. (Fig-
ure S1B). By contrast, analyses of PER1/2 flux excluded these
proteins as lysosomal targets (Figures 1E and 1F). Interestingly,
BMAL1, CLOCK, and REV-ERBa (Figures 1G–1I) each displayed
greater net flux/degradation in lysosomes compared with CRY1
(comparisons of individual flux rates in Figure 1J); however, the
temporal pattern of degradation of each of these proteins was
distinct from that of LC3 and CRY1 (Figures 1C and 1D). For
instance, lysosomal degradation of BMAL1 occurred at high
rates between 7 a.m. and 3 p.m. and at 3 a.m. that were sepa-
rated by decreased lysosomal degradation at 11 p.m. (Fig-
ure 1G). The lysosomal degradation of CLOCK occurred
maximally at 11 a.m. and 3 a.m. with reduced turnover at
7 p.m. (Figure 1H). By contrast, lysosomal degradation of REV-
ERBa increased gradually from 7 a.m. to 3 p.m. followed by a
rapid decline in its degradation for the rest of the period (Fig-
ure 1I). Increases in circadian protein levels in leupeptin-treated
samples were due to their accumulation in lysosomes and not
from increased gene expression since equivalent expression of
Bmal1, Clock, and Cry1 genes was observed in livers from con-
trol and leupeptin-treatedmice (Figures S1C–S1E). These results
demonstrate that BMAL1, CLOCK, REV-ERBa, and CRY1
proteins are lysosomal substrates and exhibit distinct temporal
patterns of lysosomal degradation (Figure 1J).
To validate that CRY1 is degraded in lysosomes in a temporal
manner, we subjected livers harvested at 7 a.m. and 7 p.m. from
ad libitum-fed mice to immunostaining for CRY1 and lysosomal
marker LAMP1. Consistent with results from lysosomal flux ana-
lyses (Figure 1B), immunofluorescence (IF) revealed an increase
in co-localization of CRY1with LAMP1 at 7 p.m., but not at 7 a.m.
(Figure S1F). We also noted a remarkable increase in LAMP1
signal in livers at 7 p.m. (Figure S1F), indicating expansion of
lysosome-related acidic organelles at 7 p.m. compared with
livers at 7 a.m., which we confirmed by demonstrating 50%
increase in Lamp1 gene expression at 7 p.m. compared with
7 a.m. (Figure S1G). Lysosomal expansion likely contributed to
induction of LC3-II/autophagy flux and CRY1 degradation at
7 p.m. (Figures 1C and 1D).
Since LC3 and CRY1 were degraded over a similar time
course, we next explored whether degradation of CRY1 is
LC3 dependent. Consequently, we first tested whether CRY1
is sequestered by APhs. APhs were isolated from liver by den-
sity gradient centrifugation (Marzella et al., 1982) and fractions
were validated by their enrichment of APh marker LC3-II by
immunoblotting (Figure 1K). Consistent with increased CRY1
flux at 7 p.m. (Figure 1D), APhs from 7 p.m. livers were enriched
in CRY1, but not BMAL1/CLOCK (Figures 1G, 1H, and 1K),
indicating that CRY1 is sequestered by APhs and thereby
degraded by autophagy. Although lack of PER2 accumulation
in the presence of leupeptin excludes it as an autophagy sub-
strate (Figure 1F), PER2 co-purified with CRY1 in APhs at
7 p.m. (Figure 1K). Co-immunoprecipitation (coIP) analyses
from livers at 7 p.m. confirmed that LC3 interacts with CRY1
and PER2, but not PER1, BMAL1, or CLOCK (Figure 1L).
CoIP analyses at 3 p.m. revealed the interaction of CRY1270 Cell Metabolism 28, 268–281, August 7, 2018with LC3, but not PER2 (Figure 1M), supporting that CRY1 is
degraded by autophagy.
Autophagy Degrades CRY1 in a Time-Dependent
Manner
Three distinct mechanisms deliver cargo to lysosomes: macro-
autophagy (or autophagy) (He and Klionsky, 2009), chaperone-
mediated autophagy (CMA) (Cuervo, 2010), and endosomal
microautophagy (eMI) (Sahu et al., 2011). Loss of Atg7 blocks
APh formation and autophagy but has no effect on CMA (Park
et al., 2015; Rodriguez-Muela et al., 2013) and eMI (Sahu
et al., 2011). Since CRY1 was detected in APhs and interacted
with LC3, we sought to confirm whether CRY1 is an autophagy
substrate. Consequently, we depleted the autophagy gene Atg7
in livers of Atg7 floxed mice by tail vein injections of AAVs
expressing Cre recombinase (hereafter Atg7KO) for 7 and
13 days. We intended to establish a model of short-term auto-
phagy inhibition in vivo such that adverse effects of prolonged
autophagy suppression are eliminated. Depleting Atg7 in livers
for 7 and 13 days each blocked autophagy, indicated by
decreased ATG7 and LC3-II levels, although complete loss of
ATG7 and accumulation of autophagy cargo p62 were
observed after 13 days of Cre injections (Figure 2A). Impor-
tantly, loss of Atg7 for 7 or 13 days each led to accumulation
of CRY1, but not CRY2 (Figure 2A). In addition, accumulation
of CRY1 in Atg7-deficient livers was detected in tissue homog-
enates and cytosol, and in nuclear fractions (validated by
enrichment of nuclear marker Lamin A/C) where CRY1 translo-
cates to repress BMAL1/CLOCK transcriptional activity (Fig-
ure 2B). Since the SCF complex ubiquitinates CRY1 for protea-
somal degradation (Xing et al., 2013), and since autophagy
degrades cargo ‘‘in bulk,’’ we explored whether SCF compo-
nents that associate with CRY1 might also be degraded by
autophagy at 7 p.m. Interestingly, APhs from livers of wild-
type (WT) mice at 7 p.m. were enriched in SCF components
Skp1 and FBXL3 (Figure S2A). Furthermore, Atg7-null livers dis-
played 2-fold increase in CRY1, 4-fold increase in Skp1, and
30% increase in FBXL3 levels (Figure S2B), suggesting that
autophagy degrades components of the SCF complex in addi-
tion to CRY1. Although lysosomal flux analyses showed
decreased turnover of BMAL1 and CLOCK in Atg7KO livers
(Figure S2C), BMAL1 and CLOCK did not interact with LC3,
enrich in APhs (Figures 1K–1M), or accumulate in Atg7-deficient
livers (Figure 2C), excluding them as macroautophagy targets.
Dampened BMAL1/CLOCK flux in Atg7KO livers likely resulted
from modest decreases in BMAL1/CLOCK protein levels (Fig-
ure 2C) secondary to decreased Bmal1 and Clock gene expres-
sion (Figures 2J–2M).
Loss of Autophagy Disrupts the Circadian Clock in Liver
Since CRY1 is degraded by autophagy, we investigated the
effect of loss of Atg7 on oscillations of the liver clock across
period. Deletion of Atg7 resulted in loss of LC3-II and accumula-
tion of LC3-I at each time point, indicating loss of autophagy (Fig-
ures 2C and 2D). As anticipated, loss of autophagy resulted in
accumulation of CRY1 at each time point; however, no increases
in CRY2 protein levels were noted (Figures 2C, 2E, and S2D).
Increased CRY1 protein levels block BMAL1/CLOCK transcrip-
tional activity, leading to repression of Cry1 gene; hence,
Figure 2. Autophagy Specifically Degrades
CRY1 and Regulates the Liver Clock
(A and B) IB for indicated proteins in livers from
Atg7flox/flox mice subjected to tail vein injections of
control (Con) and Cre-expressing AAVs for 7 or
13 days, and liver homogenates (Hom), cytosol
(Cyt), and nuclear (Nuc) fractions from mice in-
jected withCre-expressing AAVs for 13 days; n = 6.
Quantification for (B) is shown.
(C–O) (C–E, G, I, J, L, and N) IB and quantification
for indicated proteins in blots in (C), and (F, H, K,M,
and O) RT-PCR for corresponding circadian genes
from livers harvested at six indicated time points
across 24 hr from ad libitum-fedmalemice injected
with Con or Cre-expressing AAVs (Atg7KO) for
13 days; n = 5–7.
Values are mean ± SEM. *p < 0.05, **p < 0.01,
***p < 0.001; compare values in Atg7KO mice with
corresponding values in Con mice. Student’s t test
or two-way ANOVA and Bonferroni correction.
Ponceau is the loading control. See also Figure S2.abundance of CRY1 in Atg7-deficient livers should, in principle,
dampen Cry1 expression. Indeed, Atg7-deficient livers showed
significantly decreased Cry1 expression across period (Fig-
ure 2F), suggesting a functional increase in CRY1-driven repres-
sion of BMAL1/CLOCK activity. Atg7-deficient livers displayed a
reduction in PER1 protein levels that could not be explained by
changes in Per1 expression, while PER2 protein levels remained
largely unaffected (Figures 2G–2I). Atg7-deficient livers also
displayed decreased BMAL1 protein levels and Bmal1 gene
expression (Figures 2J and 2K) and modestly reduced CLOCK
levels at 3 p.m. that were associated with decreased Clock
expression (Figures 2L and 2M). Levels of REV-ERBa protein
(Figure 2N) and Rev-erba and Rev-erbb gene expression were
also suppressed in Atg7-deficient livers (Figures 2O and S2E),
reflecting an overall trend toward dampening of the oscillations
of the liver clock in absence of autophagy. Reduction of Bmal1
expression in Atg7KO livers likely occurred due to decreased
expression ofRora (Figure S2F), which encodes for RORa, which
drives Bmal1 gene expression (Guillaumond et al., 2005; Sato
et al., 2004). In sum, these results indicate that loss of autophagy
disrupts the liver clock.Cell MeLoss of Autophagy Affects Nuclear
and Cytoplasmic Levels of Core
Circadian Proteins
Nucleocytoplasmic shuttling of circadian
proteins and degradation of PER/CRY
each modulate period length. Because
blocking autophagy resulted in accumu-
lation of CRY1 and decreases in levels
of BMAL1, CLOCK, and REV-ERBa, we
characterized in greater detail the effect
of loss of autophagy on period-wide oscil-
lations of these proteins in nuclear and
cytoplasmic compartments. To that pur-
pose, livers were harvested at 7 a.m., 11
a.m., 3 p.m., 7 p.m., 11 p.m., and 3 a.m.
from control and Atg7-deficient livers
(13 days after a single AAV-Cre injection),following which nuclear and cytosolic fractions were generated.
Autophagy deficiency was verified by accumulation of LC3-I in
both nuclear and cytosolic fractions from Atg7KO mice (Figures
3A–3C), while nuclear enrichment was confirmed by abundance
of nuclear marker Lamin A/C and its absence in cytosolic frac-
tions (Figure S3A). As expected, biochemical fractionation and
IF revealed 2- to 3-fold increase in CRY1 accumulation in nu-
cleus in livers from Atg7KO mice (Figures 3A, 3D, and 3E).
Although both nuclear and cytosolic fractions from Atg7KO
mice showed increased CRY1 accumulation (Figures 3A–3E),
greater retention of CRY1 was observed in the nucleus than
cytoplasm (Figure 3D). These findings are consistent with the
fact that CRY1 exerts its repressive function by nuclear translo-
cation. We next explored the effect of loss of autophagy on
oscillations of additional core circadian proteins in nuclear
and cytoplasmic compartments. Consistent with decreased
BMAL1/CLOCK protein levels in homogenates (Figures 2J and
2L), BMAL1 and CLOCK levels were also decreased in nuclear
fractions from Atg7KO livers compared with controls (Figures
3F and 3G). Modest reduction in BMAL1 protein was also de-
tected in cytoplasm from Atg7KO livers at 7 a.m. (Figure 3F),tabolism 28, 268–281, August 7, 2018 271
Figure 3. Loss of Autophagy Affects Nuclear Levels of Core Circadian Proteins
(A–D and F–H) IB for nuclear and cytosolic distribution of indicated circadian proteins, autophagy-related protein LC3, FBXL3, Skp1, and FBXL21 in livers across
24 hr from ad libitum-fed male mice injected with Con orCre-expressing AAVs (Atg7KO) for 13 days; n = 4–8. Quantifications for nuclear and cytosolic distribution
of LC3, CRY1, BMAL1, CLOCK, and FBXL3 are depicted. Quantifications for nuclear and cytosolic distribution of PER1, PER2, REV-ERBa, Skp1, and FBXL21 are
shown in Figure S3.
(E) Indirect IF for CRY1 (green) in livers and quantification for nuclear and total cellular CRY1 content at 7 p.m. in livers from ad libitum-fed male mice injected with
Con or Cre-expressing AAVs (Atg7KO) for 13 days; n = 4. Scale bar, 10 mm.
Values are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001; compare values in Atg7KO mice with corresponding values in Con mice. Student’s t test or two-way
ANOVA and Bonferroni correction. Ponceau is the loading control. See also Figure S3.although the significance of this finding remains unclear. Consis-
tent with our observations in total homogenates, nuclear and
cytoplasmic levels of PER1 and REV-ERBa were also signifi-
cantly reduced across period in Atg7KO livers, while no changes272 Cell Metabolism 28, 268–281, August 7, 2018in PER2 levels were detected (Figures S3B–S3D). Taken
together, these findings reflect a remarkable dampening in the
oscillations of core circadian genes, a hallmark of age-associ-
ated changes in rhythmicity (Cornelissen and Otsuka, 2017;
Zwighaft et al., 2015). Given that autophagy decreases with age
(Rubinsztein et al., 2011), our data suggest that defects in auto-
phagy may contribute to the recently elucidated effects of aging
on the molecular clock.
Because loss of Atg7 led to accumulation of CRY1 and SCF
complex (FBXL3 andSkp1) (Figure S2B), which facilitates ubiqui-
tination/degradation of CRY1 (Xing et al., 2013), we next charac-
terized the effect of loss of autophagy on period-wide changes in
nuclear and cytoplasmic levels of FBXL3 and Skp1. Interestingly,
loss of autophagy led to accumulation of FBXL3 and Skp1 in the
nucleus across the period, although increases in both molecules
occurredmost significantly at 3a.m. (Figures3HandS3E). FBXL3
did not accumulate in cytosolic fractions; however, a significant
increase in cytosolic Skp1 accumulation was noted in Atg7KO
livers at 3 a.m. (Figure S3E). While the mechanism of sequestra-
tion of nuclear FBXL3 by autophagy is unclear, given the enrich-
ment of CRY1, FBXL3, andSkp1 in APhs, our results suggest that
CRY1 and SCF are likely degraded by autophagy as a complex.
Since cytoplasmic FBXL21, another member of the F-box-type
E3 ubiquitin ligase family (Jin et al., 2004), opposes the function
of FBXL3 and promotes CRY1 stability (Hirano et al., 2013; Yoo
et al., 2013), we testedwhether loss of autophagy led to accumu-
lationof FBXL21,which, in turn, increasedCRY1stability/levels in
Atg7KO livers. Loss of autophagy did not affect FBXL21 protein
levels (Figure S3F), excluding the possibility that accumulation
of CRY1 in Atg7KO livers occurred from an FBXL21-dependent
increase in CRY1 stability.
Autophagic Degradation of CRY1 Sustains
Gluconeogenesis
Since depleting ATG7 in livers increases CRY1 levels, and since
CRY1 suppresses gluconeogenesis (Jang et al., 2016; Lamia
et al., 2011; Zhang et al., 2010), we hypothesized that autophagic
degradation of CRY1 maintains blood glucose levels by driving
gluconeogenesis. Consistent with previous work showing a
role for autophagy in preventing hypoglycemia (Karsli-Uzunbas
et al., 2014), Atg7 floxed mice displayed significant reduction
in blood glucose levels when tested at 7 p.m. as early as
3 days after Cre injections (Figure 4A). After a week of Cre injec-
tions, Atg7KO mice showed lower blood glucose at each time
point across the circadian period, demonstrating that hepatic
autophagy is required to maintain blood glucose levels (Fig-
ure 4B). Reduced blood glucose levels did not occur from
decreased glycogen breakdown by autophagy since acute
loss of Atg7 in livers associated with diminished hepatic
glycogen stores across the period (Figure S4A). In fact, livers
from Atg7KO mice were largely depleted of glycogen compared
with controls, indicating significant deficiency in glucose pro-
duction/storage in liver. Although Atg7KO mice consumed less
food in the nocturnal cycle, both control and Atg7KO mice
consumed equal amounts of food in the diurnal cycle, excluding
differences in diurnal feeding as the reason for reduced blood
glucose levels (Figure S4B).
Mice rely ongluconeogenesis tomaintaindiurnal bloodglucose
levels since they consume a significant proportion of their total
calories in the early hours of the dark cycle. To begin to test
whether lower blood glucose levels in Atg7KO mice occurred
from decreased gluconeogenesis, we first characterized the tem-
poral changes in expression of gluconeogenic genes in normalmice across the circadian period. While livers from ad libitum-
fed control mice showed progressive increases (2-fold) in
expression of gluconeogenic genes G6p, Pck1, and Pc between
3 p.m. and 7 p.m., Atg7-deficient livers failed to induce these
genes at similar time points (Figures 4C–4E). Atg7KO mice were
also unable to increase their blood glucose levelswhen subjected
to pyruvate tolerance tests (PTTs) at 6 p.m, indicating impaired
gluconeogenesis (Figure 4F). The transcription factor FoxO1
translocates to the nucleus and drives gluconeogenesis during
reduced feeding when insulin levels are low (Puigserver et al.,
2003), and because CRY1 participates in the degradation of nu-
clear FoxO1 (Jang et al., 2016), we tested whether decreased
gluconeogenesis in Atg7KOmice is associated with reduced nu-
clear FoxO1 content. Indeed, Atg7KO livers displayed a signifi-
cant reduction in nuclear FoxO1 levels compared with controls
(Figures 4G and 4H), while cytoplasmic FoxO1 levels remained
largely unaffected (data not shown). Reduction in nuclear FoxO1
levelsdid not occur from its retention in the cytoplasmsince circu-
lating levels of insulin, a factor that drives FoxO1 phosphorylation
and cytoplasmic retention, were largely reduced in Atg7KOmice
(Figure S4C). Given the accumulation of CRY1 in Atg7KO livers
(Figures 3A, 3D, and 3E), it is likely that reduction in nuclear
FoxO1 results from CRY1-mediated degradation of FoxO1, as
shown recently (Jang et al., 2016). Decreased gluconeogenesis
in Atg7KO mice could not be explained by changes in nuclear
levels of phosphorylatedCREB,which is known to activate gluco-
neogenesis (Koo et al., 2005). In fact, nuclear levels of phosphor-
ylatedCREBwereelevated from7p.m. to11p.m. inAtg7KO livers
(Figure 4I) and circulating glucagon (Figure S4D), which phos-
phorylates CREB and drives gluconeogenesis (Koo et al., 2005),
was also significantly elevated in Atg7KO livers (Figures 4G, 4I,
and 4J). In sum, decreased gluconeogenesis in Atg7KO livers
correlated with reduced nuclear FoxO1 levels, which suggests
that FoxO1 plays a key role in aberrant glucose homeostasis in
these animals, while induction of glucagon/CREB signaling in
Atg7KO mice is a compensatory attempt to unsuccessfully
restore blood glucose levels.
More importantly, to determine whether suppression of gluco-
neogenesis in Atg7KOmice occurs from increased CRY1 levels,
we tested whether dampening CRY1 levels in Atg7-deficient
livers (by injecting small hairpin RNAs [shRNAs] against CRY1)
(Figure 4K) prevents the reduction in blood glucose levels. While
reducing Cry1 expression by 80% (Figure S4E) and CRY1 pro-
tein levels by 50% (Figure S4F) failed to affect blood glucose
levels in control mice (Figure 4L), dampening Cry1 expression
in Atg7KO livers increased blood glucose levels from 75 ± 2 to
102 ± 4mg/dL at 7 p.m. (p < 0.001) (Figure 4L). Increases in blood
glucose levels in Atg7KOmice after depletion of CRY1 occurred
specifically between 3 p.m. and 9 p.m., which coincides with the
circadian interval when autophagy maximally degrades CRY1
(Figures 1C and 1D). These data show that degradation of
CRY1 by autophagy occurs during the day when mice consume
less food, and that autophagic degradation of CRY1 sustains
blood glucose levels.
Identifying CRY1 LIR Motifs that Regulate Its
Degradation by Autophagy
To determine the mechanism of degradation of CRY1 by auto-
phagy, we first examined for presence of canonical LIR motifCell Metabolism 28, 268–281, August 7, 2018 273
Figure 4. Autophagic Degradation of CRY1 in Liver Controls Gluconeogenesis
(A) Blood glucose levels at 7 p.m. on indicated days after Atg7flox/flox male mice were injected with control (Con) or Cre-expressing AAVs (Atg7KO); n = 4.
(B–F) Blood glucose levels (n = 6–12) and expression of gluconeogenic genesG6p, Pck1, and Pc in liver, and intraperitoneal PTT frommale mice at indicated time
points across 24 hr on day 7 after injections of Con or AAV-Cre; n = 4.
(G–J) IB for indicated proteins in the nucleus in livers at indicated time points across 24 hr from Con and Atg7KO male mice. Quantifications for nuclear levels of
indicated proteins are shown; n = 4–5.
(K and L) Experimental plan showing assessment of blood glucose levels at indicated time points on day 7 after Con and AAV-Cre injections (i.e., 1 day after tail
vein injections of AAVs expressing Con or shCRY1 constructs on day 6); n = 3–10. Graph depicts blood glucose values at 7 p.m.; n = 10.
Values are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001; n.s., not significant; compare values in Atg7KO mice with corresponding values in Con mice.
###p < 0.001; compare indicated values in Con mice with 7 a.m. values in Con mice. Student’s t test or one-way or two-way ANOVA and Bonferroni correction.
Ponceau is the loading control. See also Figure S4.
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Figure 5. LIR Motifs Determine CRY1 Degradation and Regulation of Gluconeogenesis
(A) Murine CRY1 has 13 LIR motifs (green).
(B) Inactivation of selected LIR motifs (mLIR1-4) on CRY1 via mutagenesis of tyrosine (Y), valine (V), or leucine (L) residues (green) to alanine (A) (red).
(C) IB for FLAG in livers frommale mice at 7 p.m. expressing FLAG-taggedWT-CRY1 plasmid or each FLAG-tagged CRY1 LIRmutant plasmid (mLIR1–4); n = 12.
(D) IB for LC3 in livers from male mice at 7 p.m. expressing FLAG-taggedWT-CRY1 or each CRY1 LIR mutant (mLIR1–4) and cultured in presence or absence of
Lys Inh for 2 hr; n = 7–10.
(E and F) IB for BMAL1 and G6P in livers from male mice at 7 p.m. expressing FLAG-tagged WT-CRY1 plasmid or each CRY1 LIR mutant plasmid (mLIR1–4);
n = 8–12.
(legend continued on next page)
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W/F/Y-X-X-I/L/V sequences in CRY1 (Birgisdottir et al., 2013).
We identified 13 putative LIRs on CRY1 (Figure 5A), which
were prioritized for mutagenesis based on their accessibility
determined by visualization of crystal structure of mouse CRY1
(PDB: 5T5X) (Michael et al., 2017) using the Swiss-PdbViewer
software (http://www.expasy.org/spdbv/) (Guex and Peitsch,
1997), and on presence of negatively charged residues in the vi-
cinity of LIRmotifs that facilitate binding to LC3 (Birgisdottir et al.,
2013). This revealed four LIR motifs on CRY1 as candidates for
interaction with LC3, which were individually inactivated in
FLAG-tagged CRY1 plasmid by mutating their tyrosine, valine,
or leucine residues to alanine (Figure 5B). We then determined
the role of each LIR motif in degradation of CRY1 by expressing
FLAG-tagged WT-CRY1 plasmid and each CRY1 mutant LIR
plasmid (mLIR1, mLIR2, mLIR3, and mLIR4 as in Figure 5B) in
liver via tail vein injections using the jet-PEI in vivo transfection
system (Chang et al., 2014) (Figure S5A). We also explored
whether blocking autophagic degradation of CRY1 by inactivat-
ing its LIRs affects gluconeogenesis. Prior to injecting mice with
mLIR CRY1 plasmids, we tested the robustness of the experi-
mental system by determining the degree to which expression
of FLAG-tagged WT-CRY1 suppresses hepatic gluconeogen-
esis compared with empty vector. As reported in cultured
hepatocytes (Jang et al., 2016), expressing WT-CRY1 in livers
(Figure S5B) decreased the expression of gluconeogenic genes
Pck1 and G6p by 80%–90% (Figure S5C) and lowered blood
glucose levels by 50% (50 mg/dL) at 7 p.m. (Figure S5D). We
then titrated the dose of injected WT-CRY1 plasmid such that
blood glucose levels were consistently maintained at 80–
90 mg/dL between 1 p.m. and 7 p.m. Consistent with the idea
that inactivating LIR motifs on CRY1 prevents its degradation,
expressing each of the four FLAG-tagged mLIR CRY1 in liver
led to varying degrees of accumulation of FLAG compared
with WT-CRY1 (Figure 5C). Strikingly, mLIR1-CRY1 and
mLIR4-CRY1 accumulated significantly more than mLIR2-
CRY1 and mLIR3-CRY1 or WT-CRY1. Levels of mLIR2 and
mLIR3 CRY1 were moderately higher than WT-CRY1, but differ-
ences between these groups remained statistically insignificant
(Figure 5C). These results indicate that LIR1 (271DLYKKV276)
and LIR4 (492SRYRGL497) are required for degradation of CRY1
by autophagy. Accumulation of mLIR1-CRY1 and mLIR4-
CRY1 did not occur from reduced autophagy per se, indicated
by equivalent LC3-II flux in livers injected with WT or mLIR-
CRY1 plasmids (Figure 5D), or from changes in transfection
determined by qPCR showing equivalent Cry1 expression in
livers injected with WT and mLIR-CRY1 plasmids (Figure S5E).
CoIP in 293T cells confirmed that interactions of mLIR1-CRY1
and mLIR4-CRY1 with GFP-tagged LC3 were remarkably
reduced compared with WT-CRY1, mLIR2-CRY1, or mLIR3-
CRY1 (Figure S5F). These results are consistent with significant
accumulation of mLIR1-CRY1 and mLIR4-CRY1 and moderate
accumulation of mLIR2 and mLIR3 CRY1 in liver compared
with WT-CRY1 (Figure 5C). Consistent with our observation(G–K) Blood glucose levels at indicated time points (n = 9–16) and intraperitoneal
each CRY1 LIR mutant plasmid in liver; n = 5. AUC, area under the curve.
(L) Cartoon summarizing temporal autophagic degradation of CRY1 and its effec
Values are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. Student’s t test, on
control. See also Figure S5.
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decreased BMAL1 levels (Figure 2J), accumulation of mLIR1-
CRY1 or mLIR4-CRY1 each associated with reduced BMAL1
levels (Figure 5E), indicating that expressing autophagy-resistant
forms of CRY1 is sufficient to disrupt the liver clock.
LIR Motifs Link CRY1 Degradation to Regulation of
Gluconeogenesis
Since increases in hepatocellular CRY1 protein inhibit gluconeo-
genesis,wenext testedwhether accumulationofmLIR1-CRY1or
mLIR4-CRY1 was sufficient to suppress hepatic glucose
production/blood glucose levels. Indeed, mice injected with
mLIR1-CRY1 or mLIR4-CRY1, but not mLIR2-CRY1 and
mLIR3-CRY1 constructs, displayed reduced G6P protein levels
(Figure 5F) and decreased blood glucose levels at 7 p.m. (Figures
5G–5J). Furthermore, mLIR1-CRY1- or mLIR4-CRY1-injected
mice, and not the mLIR2-CRY1- and mLIR3-CRY1-injected
mice, exhibited less glucose production when subjected to
PTTs (Figure 5K), indicating that LIR motifs 271DLYKKV276 and
492SRYRGL497 link CRY1 turnover by autophagy to regulation
of gluconeogenesis. Most surprisingly, CRY1 LIR2
(285SLYGQL290) and LIR4 (492SRYRGL497) are also required for
degradation of SCF components Skp1 and FBXL3by autophagy,
since livers injected with mLIR2-CRY1, mLIR3-CRY1, and
mLIR4-CRY1 each showed accumulation of these proteins
compared with WT-CRY1 or mLIR1-CRY1 (Figure S5G). These
data suggest that SCF components Skp1 and Fbxl3 are likely tar-
geted for autophagic degradation via their associationwithCRY1
(Xing et al., 2013), which, in turn, binds to LC3 via its LIR motifs.
High-Fat-Diet Feeding Decreases CRY1 Protein Levels
in Liver
Because obesity dysregulates gluconeogenesis and given our
finding that autophagic turnover of CRY1 derepresses hepatic
gluconeogenesis under physiological states, we hypothesized
that obesity accelerates the degradation of CRY1 by autophagy,
which increases glucose production. To test this hypothesis,
C57BL/6J male mice were fed a regular chow diet (RD) or
high-fat diet (HFD; 60% calories in fat) for 8 weeks, following
which livers were collected at 7 a.m., 11 a.m., 3 p.m., 7 p.m.,
11 p.m., and 3 a.m. and assessed for period-wide changes in
(1) expression of gluconeogenic genes and (2) levels of core
circadian proteins and the autophagy protein LC3. As expected,
HFD feeding for 8 weeks significantly increased expression of
gluconeogenic genes G6p, Pck1, Fbp1, and Pc in liver (Figures
S6A–S6D). Although we noted qualitative differences in the
patterns of their expression across period, a unifying feature
wasmaximal induction of gluconeogenic genes at 7 p.m. Conse-
quently, we tested whether increased gluconeogenic gene
expression at 7 p.m. correlated with decreased CRY1 protein
levels in nuclear and cytoplasmic compartments from livers of
HFD-fed mice. Indeed, period-wide assessments in livers re-
vealed that HFD feeding progressively decreased nuclear andPTT at 6 p.m. from male mice expressing FLAG-tagged WT-CRY1 plasmid or
ts on gluconeogenesis and blood glucose levels.
e-way or two-way ANOVA and Bonferroni correction. Ponceau is the loading
Figure 6. High-Fat Feeding Decreases CRY1 Protein Levels in Liver
(A–K) IBs and quantifications for indicated proteins in nuclear and cytosolic fractions from livers at indicated time points frommalemice fed regular chow diet (RD)
or high-fat diet (HFD; 60% calories in fat) for 8 weeks. n = 4–8.
Values are mean ± SEM *p < 0.05. **p < 0.01. Two-way ANOVA and Bonferroni correction. Ponceau is the loading control. See also Figure S6.cytosolic CRY1 levels (Figures 6A, 6B, and 6D) that were associ-
ated with increased levels of the autophagosome marker LC3-II
in both nuclear and cytosolic fractions (Figures 6A–6C). Reduc-
tion in CRY1 levels did not occur from changes in expressionof repressor genes Cry1 or Per1 (Figures S6E and S6F). Indeed,
while HFD feeding moderately decreased Cry1 gene expression
at 3 a.m. and 7 a.m., no differences were observed between
RD- and HFD-fed mice from 11 a.m. to 11 p.m., the broadCell Metabolism 28, 268–281, August 7, 2018 277
interval when CRY1 regulates gluconeogenesis (Figure S6E).
These data suggest that early obesity, as observed with 8 weeks
of HFD feeding, is sufficient to promote CRY1 protein instability.
HFD feeding did not have a remarkable effect on levels of the
other core circadian proteins (Figure 6), although we did note
an interesting trend toward slight increases in nuclear levels of
PER1, PER2, and REV-ERBa and reduction in their correspond-
ing levels in the cytosol (Figures 6E, 6F, and 6I). Nuclear and cyto-
solic levels of BMAL1weremodestly decreased in the early hours
of the light cycle, which correlated with decreased Bmal1 gene
expression in livers from HFD-fed mice (Figures 6G and S6G),
as shown previously (Eckel-Mahan et al., 2013). Conversely,
modest increases in cytosolic CLOCK protein after 3 p.m. corre-
lated with increased Clock gene expression (Figures 6H and
S6H). HFD feeding modestly increased cytoplasmic FBXL3 and
nuclear FBXL21 levels and did not affect levels of Skp1 (data
not shown); however, these changes do not explain the instability
of CRY1 in HFD-fed mice (Figures 6J and 6K). Taken together,
these data show that moderate duration of HFD feeding is suffi-
cient to decrease CRY1 protein levels in liver, forming the basis
to explore whether decreases in CRY1 through autophagic
degradation promote gluconeogenesis during early obesity.
Obesity Promotes Degradation of CRY1 in an
Autophagy-Dependent Manner
Given these results, we asked whether HFD-feeding-induced
CRY1 degradation is autophagy dependent. To that purpose,
we subjected liver lysates from RD- and HFD-fed control and
Atg7KOmice to immunoblotting for CRY1, while CLOCK served
as a control. WhileAtg7 loss in RD- or HFD-fedmice (Figure S7A)
did not affect CLOCK protein levels at 7 p.m. (Figures 7A and 2L),
loss of Atg7 (as early as 7 days after AAV-Cre injection) blocked
the degradation of CRY1 in livers from HFD-fed mice by 50%
(Figure 7A), demonstrating that autophagy contributes to CRY1
instability in HFD-fed mice (Figure 6D).
Restoring CRY1 Levels Prevents Obesity-Associated
Dysregulation of Gluconeogenesis
To mechanistically link autophagic degradation of CRY1 to
increased hepatic gluconeogenesis in obese mice, we tested
whether two distinct approaches to reconstitute hepatic CRY1
levels in obese mice will normalize glucose metabolism. Conse-
quently, RD-fed C57BL/6J mice were subjected to PTT on day 1
prior to initiating them on HFD (60% calories in fat) for 8 weeks
(plan in Figure S7B). After 7 weeks of HFD feeding, mice were
subjected to a second PTT and then rested for 7 days, following
which mice were tail-vein-injected with cDNA expressing
WT-CRY1 and administered a PTT the next day (Figure S7B).
Restoring CRY1 levels (5-fold increase in Cry1 expression in
liver) (Figure S7C) was sufficient to lower blood glucose levels
by 50% in HFD-fed mice (Figure 7B), which associated with
remarkable inhibition in expression of Pck1,G6p, and Fbp1 (Fig-
ures S7D–S7F) and normalization of glucose production in a PTT
compared with HFD-fed controls (Figure 7C). In addition, knock-
ing out Atg7 in 8-week HFD-fed mice (Figure 7D) increased
hepatic CRY1 levels by 50% (Figure 7A), reduced glucose
production in a PTT (Figure 7E), and decreased the expression
of Fbp1, G6p, Pc, and Pck1 compared with HFD-fed controls
(Figures 7F–7I). Normalization of glucose homeostasis in278 Cell Metabolism 28, 268–281, August 7, 2018HFD-fed Atg7KO mice occurred due to accumulation of CRY1
(Figure 7A) and not due to differences in Cry1 gene expression
(Figure 7J). These results demonstrate that inhibiting autophagy
in liver or targeting specific LIR motifs on CRY1 to prevent their
autophagic degradation is sufficient to normalize obesity-asso-
ciated dysregulation of gluconeogenesis, revealing LIRs on
CRY1 as therapeutic targets against hyperglycemia.
DISCUSSION
In this study, we show that autophagy in the liver degrades CRY1
during a temporal window when rodents typically eat less and
subsist on gluconeogenesis. The enrichment of CRY1 in APhs,
its interaction with LC3, and accumulation of CRY1 in auto-
phagy-deficient livers demonstrate that CRY1 is an autophagy
substrate. Site-directed mutagenesis to inactivate distinct LIR
motifs on CRY1 reveals two LIRs that regulate CRY1 degrada-
tion by autophagy. Degradation of CRY1 allows induction of
gluconeogenesis and maintenance of blood glucose levels.
Consistent with this notion, mice with Atg7-deficient livers
display increased CRY1 levels and reduced blood glucose
levels, which are rescued in part by decreasing their hepatic
CRY1 content. Rescue of blood glucose occurs selectively be-
tween 3 p.m. and 7 p.m., suggesting that autophagic CRY1
degradation is time imprinted to a specific physiological func-
tion: maintenance of blood glucose levels during reduced
feeding. Awell-defined signalingmodule that induces autophagy
during nutrient depletion is AMPK, and phosphorylation by
AMPK promotes CRY1 degradation (Lamia et al., 2009).
Although AMPK primes CRY1 for proteasomal degradation,
whether phosphorylation by AMPK facilitates CRY1 sequestra-
tion by autophagy remains unknown. It is thought that phosphor-
ylation of residues in proximity to LIR motifs facilitates LIR-LC3
interaction (Birgisdottir et al., 2013). Examination of CRY1 pro-
tein revealed that serine 280, a residue phosphorylated by
AMPK, lies distal to LIR 271DLYKKV276. We have found that inac-
tivating 271DLYKKV276 led to CRY1 accumulation. It is thus
possible that introducing a negative charge in the vicinity of
CRY1 LIR could increase its degradation via autophagy, and
from that perspective, serine 280 phosphorylation could drive
CRY1 degradation by autophagy. Whether such cooperativity
determines the fate of CRY1 protein remains to be seen. We
were intrigued by the finding that PER2 and CRY1 each interact
with LC3 at 7 p.m. when CRY1 is maximally degraded by auto-
phagy, yet PER2 does not accumulate in autophagy-deficient
livers. We speculate that PER2, a known interacting partner of
CRY1, is a cargo adapter that facilitates interaction of CRY1
with LC3, although future studies will be required to test this
notion. We were also intrigued by the finding that SCF compo-
nents Skp1 and Fbxl3, which determine CRY1 degradation by
the proteasome, are also autophagy substrates. In the context
of this study, it would seem that reduced feeding at specific
diurnal intervals directs hepatocytes to prioritize autophagic
degradation of CRY1 and possibly CRY1-associated proteins
(e.g., Skp1 and Fbxl3), such that suppressive effects of CRY1
on gluconeogenesis are effectively neutralized. Loss of auto-
phagy resulted in pronounced accumulation of FBXL3 and
Skp1 in the nucleus, which begs further investigation on mecha-
nisms of sequestration of these nuclear-localized proteins by
Figure 7. Restoring CRY1 Prevents Obesity-Associated Dysregulation of Gluconeogenesis
(A) IB for CRY1 and CLOCK in livers from male mice fed RD or HFD for 8 weeks. Then subsets of mice were injected with control (Con) or Cre-expressing AAVs
(Atg7KO), as in (D); n = 5. KO, knockout.
(B and C) Blood glucose and PTT at indicated time points in male mice fed HFD for indicated duration (plan in Figure S7B), following which a subset of mice was
injected with WT-CRY1 for 1 day; n = 5–8.
(D and E) Experimental plan and PTT at indicated time points (before HFD feeding, 7 weeks after HFD feeding, and 1 week after AAV-Cre injection) in male mice
fed RD or HFD for 7 weeks. Then subsets of mice were injected with Con or Cre-expressing AAVs (Atg7KO); n = 5–10.
(F–J) RT-PCR for indicated genes in livers at 7 p.m. as per plan in (D); n = 4–8.
Values aremean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. Student’s t test or two-way ANOVA and Bonferroni correction. Ponceau is the loading control. See also
Figure S7.autophagy; however, these extensive cell biological excursions
are beyond the scope of the present work. Taken together, we
show that temporal degradation of CRY1 by autophagy dere-
presses hepatic gluconeogenesis, and that LIR motifs mecha-
nistically link degradation of CRY1 to regulation of gluconeogen-
esis, revealing LIRs as potential targets for glycemic control.
Limitations of Study
We find that HFD feeding accelerates the degradation of CRY1
by autophagy, which is surprising given that chronic lipid stim-ulus is thought to suppress autophagy (Singh et al., 2009). This
is an exciting finding that begs the question of how CRY1 degra-
dation is accelerated when autophagy is suppressed. These
results allow us to consider the possibility that, despite the inhib-
itory effect of obesity on autophagy, chronic lipid availability may
trigger post-translational modifications on autophagic cargo
(e.g., phosphorylations in the vicinity of LIR motifs) that could
make a subset of proteins more efficiently recognized by the re-
sidual autophagic machinery. The second limitation of our study
is the lack of experiments that reveal the relative contribution ofCell Metabolism 28, 268–281, August 7, 2018 279
the proteasome and autophagy to the degradation of CRY1. It
could be possible that autophagy and the proteasome each
regulate CRY1 levels at distinct intervals across period and likely
respond to different environmental cues. Future studies will be
required to address these limitations.STAR+METHODS
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Antibodies
Rabbit polyclonal anti-ATG7 Cell Signaling Technology Cat# 2631; RRID: AB_2227783
Rabbit monoclonal anti-BMAL1 Cell Signaling Technology Cat# 14020; RRID: AB_2728705
Rabbit monoclonal anti-CLOCK Cell Signaling Technology Cat# 5157; RRID:AB_10695411
Rabbit polyclonal anti-CRY1 Origene Cat# TA342728
Rabbit polyclonal anti-CRY2 Abcam Cat# ab38872, RRID: AB_731755
Mouse monoclonal anti-DYKDDDDK Tag Cell Signaling Technology Cat# 8146S; RRID: AB_10950495
Rabbit polyclonal anti-Fbxl3 Abcam Cat# ab96645, RRID: AB_10679381
Rabbit polyclonal anti-G6Pase Abcam Cat# ab83690, RRID: AB_1860503
Rat monoclonal anti-LAMP1 DSHB Cat# 1d4b, RRID: AB_2134500
Rabbit polyclonal anti-LC3B Cell Signaling Technology Cat# 2775; RRID: AB_915950
Human polyclonal anti-p62 Enzo Life Sciences Cat# BML-PW9860, RRID: AB_2196009
Rabbit polyclonal anti-Pyruvate Carboxylase Novus Cat# NBP1-49536, RRID: AB_10011589
Rabbit polyclonal anti-PER1 Novus Cat# NBP2-24589
Rabbit polyclonal anti-PER2 Origene Cat# TA337016
Rabbit monoclonal anti-Rev-erb a Cell Signaling Technology Cat# 13418, RRID: AB_2630359
Rabbit polyclonal anti-Skp1 Cell Signaling Technology Cat# 2156S; RRID: AB_10692507
Rabbit polyclonal anti-Fbxl3 Abcam Cat# ab96645, RRID: AB_10679381
Rabbit polyclonal anti-Fbxl21 Abcam Cat# ab222894
Secondary HRP Antibody Rabbit anti-Mouse IgG Invitrogen Cat# 61-6520, RRID: AB_2533933
Secondary HRP Antibody Goat anti-Rabbit IgG KPL 074-1506
Goat anti-Rabbit IgG (H+L) Secondary Antibody,
Alexa Fluor 488 conjugate
Thermo Fisher Scientific Cat# R37116, RRID: AB_2556544
Goat anti-Rat IgG (H+L) Cross-Adsorbed Secondary
Antibody, Alexa Fluor 647
Thermo Fisher Scientific Cat# A-21247, RRID: AB_141778
Bacterial and Virus Strains
pMC1SG5_mmCry1 Addgene 31282
mLIR1-CRY1 (271DLAKKA276) GenScript N/A
mLIR2-CRY1 (285SLAGQA290) GenScript N/A
mLIR3-CRY1 (486QIAQQA491) GenScript N/A
mLIR4-CRY1 (492SRARGA497) GenScript N/A
AAV-TBG-GFP Vector Biolabs VB1743
AAV-TBG-iCre Vector Biolabs VB1724
Ad-CMV-Null Vector Biolabs 1300
Ad-m-CRY1-shRNA Vector Biolabs shADV-256159
Chemicals, Peptides, and Recombinant Proteins
High Fat Diet (60% of calories in fat) Research Diets D12492
Leupeptin hemisulfate Fisher Scientific BP2662100
Metrizamide Sigma-Aldrich 860506
Trizol Reagent Invitrogen 15596018
Triton X-100 Sigma-Aldrich X100-500ml
Superscript II Reverse Transcriptase Invitrogen 18064014
Sodium Pyruvate Sigma-Aldrich P2256
Power SYBR Green PCR Master Mix Invitrogen 4368708
RNeasy Plus Mini kit Qiagen 74136
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30% Acrylamide/ Bis Solution 37-5-1 BioRad 161-0158
Paraformaldehyde Electron Microscopy Sciences 15714-S
Sodium Pyrophosphate Sigma-Aldrich AB02014
Sodium Chloride AmericanBio AB01915
b-Glycerophosphate Sigma-Aldrich G9891
Sodium Orthovanadate Sigma-Aldrich S6508
PMSF Sigma-Aldrich 10837091001
Sucrose AmericanBio AB01900-01000
Super Signal West Femto Maximum Sensitivity
Substrate, ECL
Pierce 34096
DAPI Fluoromount-G SouthernBiotech 0100-20
Critical Commercial Assays
NE-PER Nuclear and Cytoplasmic
Extraction Reagents
Thermo Fisher Scientific 78835
Experimental Models: Organisms/Strains
Mouse: C57BL/6 wildtype The Jackson Laboratory JAX: 000664
Mouse Atg7flox/flox Komatsu et al. (2006) N/A
Oligonucleotides




Prism Graph Pad https://www.graphpad.com/scientificsoftware/
prism/; RRID: SCR_002798
Other
StepOne Plus Real-Time PCR System Thermo Fisher Scientific 4376600
CLAMS open-circuit indirect calorimetry Columbus Instruments N/A
Leica SP5 AOBS Inverted DMI6000
confocal microscope
Leica Microsystems N/A
Ascensia Contour Glucometer Bayer 7151H
Ascensia Contour strips Bayer 7080GCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to the Lead Contact, Rajat Singh (rajat.singh@
einstein.yu.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Studies were performed in 4-6-month-old male C57BL/6 mice, and Atg7flox/flox mice (Komatsu et al., 2006) that was a kind gift from
Drs. M. Komatsu and K. Tanaka, Tokyo Metropolitan Institute of Medical Science, Japan). Atg7flox/flox mice were on the C57BL/6
background.Micewere used under a protocol approved by the Institutional Animal Care andUseCommittee. Micewere fed a regular
chow (5058; Lab Diet, St Louis, MO) or 8 weeks of HFD providing 60% calories in fat D12492; Research Diets, New Brunswick, NJ,
USA. No inclusion/exclusion criteria were used in the selection of mice for the study.
Housing
Miceweremaintained at 22-23C on 12 hr light/dark cycles (7am-7pm) in the institutional barrier facility along with sentinel cages and
are specific pathogen-free. Mice in sentinel cages are routinely tested by the Institute for Animal Studies for specific pathogens, and
health reports are evaluated at regular intervals to determine whether rodents are pathogen-free or whether a specific treatment is
required.Cell Metabolism 28, 268–281.e1–e4, August 7, 2018 e2
METHOD DETAILS
Autophagy Flux Assay
Autophagy/LC3-II flux was performed by intraperitoneal (i.p.) injection of lysosomal inhibitor (Lys Inh), leupeptin, at 40mg/kg mouse
weight injected 2 hr prior to liver collection at 7am, 11am, 3pm, 7pm, 11pm and 3am. Livers were homogenized in a buffer containing
protease and phosphatase inhibitors and immunoblotted for LC3. Autophagy flux was calculated by subtracting the densitometry
values of LC3-II or p62 in Lys Inh-untreated from Lys Inh-treated samples (Martinez-Lopez et al., 2016).
Isolation of Autophagic Structures and Nuclear Fractions
Autophagosomes (APh) and lysosomes (Lys) were isolated from livers by differential centrifugation using discontinuous density gra-
dients of metrizamide. Briefly, liver homogenates were centrifuged at 2,000 g for 5 min followed by centrifugation of supernatants at
17,000 g for 12 min. We resuspended the pellets in 1.9 ml 0.25 M sucrose and then 2.8 ml of metrizamide (85.6%) was added. We
centrifuged samples on a 26–24–20–15% metrizamide gradient at 75,334 g for 3 hr, following which the APh fraction was collected
from 15–20% interface, and Lys fraction from the 24–26% interface. Fractions were centrifuged at 24,000 g and pellets were resus-
pended in 0.25 M sucrose and analyzed. Cytosolic and nuclear fractions were isolated using ProteoExtract subcellular proteome
extraction kit (EMDMillipore, Billerica, MA) as per manufacturer’s instructions. Equivalent protein loading was verified using Ponceau
and antibodies for Lamin A/C (nucleus), LC3-II (APh), and LAMP1 (Lys).
RNA Isolation and qPCR Analyses
Total RNA was isolated using the Trizol Reagent (Invitrogen). The aqueous phase containing the RNA was loaded onto a gDNA
Eliminator Spin Column (Qiagen, USA) to eliminate genomic DNA, and RNA was isolated using the RNeasy Plus kit (Qiagen) accord-
ing to manufacturer’s instructions. Total RNA (1mg) was reverse transcribed into cDNA using Superscript II (Invitrogen), and quanti-
tative RT-PCR analyses was performed using Power SYBR Green PCR Master Mix (Applied Biosystems, UK) on a StepOne Plus
Real-Time PCR System (Applied Biosystems, UK). Values were normalized to expression of the housekeeping gene TATA-binding
protein (TBP). The mRNA expression in control samples was considered as 1 and mRNA expression in experimental samples was
represented as fold-change compared to expression in controls. Comparisons were only made for expression levels between the
same gene in control or KO samples. All reactions were performed in triplicate. Values were expressed in arbitrary units (a.u).
Plasmids and Adeno-Associated Virus (AAV) Injections In Vivo
Wildtype (WT) CRY1 plasmid (pMC1SG5_mmCry1) was a gift from Dr. Aziz Sancar (Addgene plasmid #31282) (5). CRY1 mLIR1-4
mutant plasmids were generated by site-directed mutagenesis (GenScript USA, Piscataway, NJ) and individual LIR mutations
were validated by sequencing. We injected 50 mg of WT FLAG-tagged CRY1 or mLIR CRY1 plasmids via tail vein injections using
the in vivo jet polyethylenimine (PEI) transfection reagent (Polyplus-transfection, NY) as per manufacturer’s protocols (Chang
et al., 2014; Wahlquist et al., 2014). Mice were injected at 8am and sacrificed at 7pm. Expression of the plasmid in liver was deter-
mined by immunoblotting or RT-PCR analyses. Deletion of Atg7 in liver was accomplished by tail vein injections of 109 PFU of AAVs
expressingCre recombinase andmicewere humanely killed 7-13 days after injection. Knockdown of CRY1 in liver was accomplished
by 1010 PFU of adenoviruses expressing CRY1-shRNA purchased from Vector Biolabs (Malvern, PA, USA) and injected 2 days prior
to tissue collection.
Plasmid Transfections In Vitro
Cells (293T) were co-transfected with 0.5 mg of GFP-tagged LC3 and 0.5 mg FLAG-tagged WT-CRY1 or mutant CRY1 by lipofect-
amine 3000. After 36 hr of transfection, cells were lysed and precipitated with FLAG M2 gel (Sigma-Aldrich) and eluted with FLAG
peptide (Sigma-Aldrich). Protein samples (10 mg) were resolved in 4-10% gradient gels and then transferred and membranes
were probed with anti-FLAG antibody (Sigma-Aldrich) and GFP antibody (Cell Signaling technology). Plasmid only control samples
were transfected with pcDNA3 plasmid.
Pyruvate Tolerance Test (PTT)
Mice were fasted at noon and PTT was performed at 6pm, after i.p. injections of sodium pyruvate (1.5 g/kg body weight). Blood
glucose levels were measured immediately prior to injection and at indicated timepoints after pyruvate injection using an Ascensia
Contour glucometer (Bayer).
Western Blotting
Total protein from liver was isolated in buffer containing 20mM Tris, pH 7.5, 1% Triton X-100, 1mM EDTA, 1mM EGTA, and protease/
phosphatase inhibitors. Lysates were centrifuged, and supernatants were subjected to immunoblotting by denaturing 20-50mg of
protein at 100C for 5 min in Laemmli sample buffer containing 62.5mM Tris, 2% SDS, 25% glycerol, 0.01% bromophenol blue,
and 5% b-mercaptoethanol. Samples were resolved on SDS-PAGE and transferred to nitrocellulose membranes (GE Healthcare,
USA) in transfer buffer containing 25mM Tris, 192mM glycine, 0.01% SDS, and 15% methanol using a Bio-Rad semidry transfer
cell at 150mA for 90 minutes. Membranes were blocked in 5% nonfat dry milk, 20mM Tris, 500mM sodium chloride, and 0.5%
Tween-20 for 1 hr and probed with primary antibodies.e3 Cell Metabolism 28, 268–281.e1–e4, August 7, 2018
Indirect Immunofluorescence
Livers were fixed with 4% paraformaldehyde, blocked and incubated with primary and corresponding secondary antibodies (Alexa
Fluor 488 and/or Alexa Fluor 647 conjugated) (Invitrogen). Mounting medium contained DAPI (4’,6-diamidino-2-phenylindole) to
visualize the nucleus (Invitrogen). Images were acquired on a Leica SP5 AOBS Inverted DMI6000 confocal microscope (Leica
Microsystems, Germany) using X63/1.4 oil objective. Images in each experiment were acquired at same exposure times within
the same imaging session. All images were prepared using Adobe Photoshop and subjected to identical post-acquisition manipu-
lations. Representative native images are shown. Quantification was performed after appropriate thresholding using the ImageJ
software (NIH) in a minimum of 30 cells from three or more experiments. Cellular fluorescence intensity was expressed as mean
integrated density as a function of individual cell size. Percentage colocalization was calculated using the JACoP plugin in single
Z-stack sections of native images. Acquisition and quantification of images were performed in a blinded manner.
Assessments of Circadian Feeding Patterns
Circadian feeding patterns were assessed in CLAMS/metabolic cages (Columbus Instruments, USA).
Biochemical Analyses
Serum Insulin and Glucagon (ALPCO, NH, USA) and liver glycogen levels (Sigma Aldrich, USA) were assessed using commercial kits
according to manufacturer’s instructions.
QUANTIFICATION AND STATISTICAL ANALYSIS
Mean and standard error were calculated for each studied variable. Statistical significance was determined using One-way or
Two-way ANOVA followed by Bonferroni multiple comparison test or by two-tailed unpaired Student’s t-test. *P<0.05, **P<0.01,
***P<0.001 and ###P<0.001. We performed the Shapiro-Wilk test to determine the normal distribution of the variables being tested.
All statistical analyses were performed using Prism Graph Pad (La Jolla, CA). Statistical details for each experiment including n value
are provided in the Figure legend.Cell Metabolism 28, 268–281.e1–e4, August 7, 2018 e4
